Swimmer's plots for off-label TA regiments administered to patients with (A) ATM/BRCA1/BRCA2, (B) ERBB2, and (C) BRAF V600E mutations. Each entry refers to an off-label regimen targeting patients with the companion mutations. Time to first dose adjustment refers to reduction in dose, treatment break, or treatment discontinuation. TA, targeted agent.